Breast Cancer Screening and Detection Grants – Application (By Invitation)
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Tuesday 26th, September 2023
External Deadline: Friday 29th, September 2023
Description
Breast Cancer Canada, AstraZeneca and Illumina are offering a $150K CDN research grant for innovations towards breast cancer screening and detection.
This new partnership has been formed to drive progress on screening and detection of breast cancer. There is $100K CDN in funding available to Canadian research teams who are developing novel technology in the detection of breast cancer. Illumina will help fuel the collaboration by providing an additional $50K CDN in-kind donations of sequencing consumables. Please find more information in the attached notice.
The funding is available to Canadian research teams who are developing novel technology in the detection of breast cancer. Illumina will help fuel the collaboration by providing in-kind donations of sequencing consumables.
Two Grants Available: Each Grant will include $100,000 of funding and up to $50,000 of Illumina products in-kind
Downloads
Breast-Cancer-Canada___AZ-Research-Grants-1 Call for Abstracts by JULY 28.2023